These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32759459)

  • 1. Hydroxychloroquine is no miracle cure for covid-19 infection -imaging and clinical course in an elderly female.
    Harsch IA; Skiba M; Lopatta E; Konturek PC
    Wiad Lek; 2020; 73(7):1583-1585. PubMed ID: 32759459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
    Klimke A; Hefner G; Will B; Voss U
    Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 7. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
    Allam MF; Andraous F
    Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine and COVID-19.
    Sinha N; Balayla G
    Postgrad Med J; 2020 Sep; 96(1139):550-555. PubMed ID: 32295814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
    Jakhar D; Kaur I
    Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
    [No Abstract]   [Full Text] [Related]  

  • 13. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
    Martinez Navarro W; Ly L; Segal MS; Shukla AM
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
    [No Abstract]   [Full Text] [Related]  

  • 14. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 17. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
    Islam M
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
    Piszczatoski CR; Powell J
    Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.